I am looking at this stock. Also hold Cann group. But from a consumer Viewpoint, having just commenced treatment with CBD oil, I found them good to deal with. Cannabis researcher honahlee.com.au rates all the clinics and Emyria is the only one doing research on their patients. Only downside is the IT system is not too efficient.
Ready to pop, page-5
Add EMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.6¢ |
Change
-0.004(8.00%) |
Mkt cap ! $18.81M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.6¢ | $26.77K | 563.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 130881 | 4.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 5303 | 1 |
View Market Depth
| Last trade - 16.10pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
4.6¢ |
Change
-0.004 ( 8.00 %) |
||||
| Open | High | Low | Volume | ||
| 4.8¢ | 4.8¢ | 4.6¢ | 116565 | ||
| Last updated 13.02pm 14/06/2024 ? | |||||
| EMD (ASX) Chart |